Anpario PLC
17 August 2026
Anpario plc
("Anpario", the "Group" or the "Company")
Death of Non-Executive Director
Anpario plc (AIM: ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, regrets to announce the death of Tim Pollock, non-executive director of the Company, after an illness.
The Board extends its deep condolences to Tim's family. Tim joined Anpario as non-executive director in August 2023, where he was also chairman of the Remuneration Committee and a member of the Audit and Nominations Committees.
Matthew Robinson, Chairman, commented:
"All Tim's colleagues at Anpario will be much saddened by the news of his passing. Tim's contribution to Anpario's progress, delivered from his deep industry knowledge and with his customary good-heartedness, has been much appreciated over the last three years."
The Board has been reviewing the appointment of further non-executive directors as envisaged by the QCA Corporate Governance Code and will provide updates in due course.
Enquiries
|
Anpario plc |
|
|
Richard Edwards, Chief Executive Officer |
+44(0)7776 417 129 |
|
Karen Prior, Corporate Responsibility Director & Company Secretary |
+44(0)1909 537 380 |
|
Marc Wilson, Group Finance Director |
+44(0)1909 537 380 |
|
Shore Capital |
|
|
(Nominated Adviser and Broker) |
+44 (0) 20 7408 4090 |
|
Stephane Auton |
Corporate Advisory |
|
David Coaten |
|
|
Tom Knibbs |
|
|
Henry Willcocks |
Corporate Broking |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.